Dallas-Ft. Worth, Houston New Home Markets Continue to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
560
Dallas-Ft. Worth, Houston New Home Markets Continue to Diverge

DALLAS, May 22, 2018 (GLOBE NEWSWIRE) -- Once again the two biggest new home markets in Texas went in opposite directions. Last month Dallas-Ft. Worth, the state and nation’s biggest new home market in total sales volume, saw a faster sales pace of new home sales and a jump in average home prices in April.

Houston, the second biggest new home sales market in Texas, saw its new home sales pace slow in April and its average sales price fall, according to the HomesUSA.com New Homes Sales Index and other information released today based on data from local Multiple Listing Services. Both Dallas-Ft. Worth and Houston reported similar news for February home sales activity.

The HomesUSA.com Index is a 12-month rolling average of the Days on Market (DOM) for new homes listed in the local Multiple Listing Services (MLSs) for the four largest Texas markets, including Dallas-Ft. Worth, Houston, Austin, and San Antonio. 

The pace of new home sales slowed statewide in April, from 122.49 in March to 123.78 in April. However, the sales of new homes in Dallas-Ft. Worth accelerated. The DOM decreased in Dallas from 115.39 days in March to 114.53 days in April. In Houston - as was reported for February activity - the opposite happened. Its DOM increased nearly 5 days, from 140.76 days in March to 145.37 days in April.

The new home sales pace slowed in Austin, as its DOM increased from 112.91 days in March to 113.20 days in April, while the new home sales pace ramped up in San Antonio, with the DOM decreasing from 107.57 in March to 105.93 days in April.

Ben Caballero, owner of HomesUSA.com and recently named by Guinness World Records as the top ranked real estate agent in the world based on home sales, is sharing this Texas new homes data in advance of tomorrow’s announcement by the Commerce Department on New Home Sales for March . The Commerce Department will report nationwide new home construction data at 10:00 am Eastern, tomorrow, Wednesday, May 23.

“If you look at the trend lines over the last year, when it comes to the pace of new home sales, Dallas and Houston are going in the opposite direction,” said Caballero. “The strength of the Dallas-Ft. Worth new home sales market continues to impress,” he said, adding, “and the slowing sales pace in Houston is looking more like a trend than a bump in the road. Overall, Austin and San Antonio are still posting impressive new home market numbers, and the Texas economy is not showing any major signs of slowing down.”

New home prices continue to stabilize Statewide home prices remain fairly stable, which is great news for new home buyers. The statewide average new home price fell slightly from $350,301 in March to $349,542 in April.

Dallas-Ft. Worth average new home prices went higher in April, climbing from $356,108 in March to $357,340. Houston’s average new home prices fell significantly, from $357,414 in March to $354,750.

In Austin, the average new home price fell slightly from $369,407 in March to $368,643 in April. The average new home price in San Antonio dropped slightly $292,866 in March to $292,648 in April. ( See Chart 1 – Texas New Home Sale Prices )

Texas New Home Sales Strong, But Growth Relatively Flat While new home sales were strong statewide in Texas for April, sales growth was relatively flat. The rolling 12-month average of new home sales statewide was up from 3,655 in March to 3,672 in April. That’s according to data compiled by HomesUSA.com from local MLS and trade associations, including the Houston Association of REALTORS, North Texas Real Estate Information Systems, San Antonio Board of REALTORS and the Austin Board of REALTORS.

The state’s two biggest markets – Dallas-Ft. Worth and Houston – both experienced relatively flat home sales in April. According to HomesUSA.com, Dallas-Ft. Worth home sales in April were 1,338, down slightly from 1,340 sales in March. Houston home sales in April were 1,207, up from 1,198 sales in March.

New home sales were up in Austin from 638 in March to 644 in April. In San Antonio, home sales were also higher last month with 483 sales in April, up from 479 sales in March. ( See Chart 2 - New Home Sales | Texas )

Understanding the new “Days on Market” Index Caballero notes the average Days on Market for New Homes “is about 65 days higher for new homes than for existing or ‘pre-owned’ homes.” Why?

“There’s a huge difference between selling a new home and a pre-owned or existing home,” Caballero explained. “New homes are often listed for sale during the early stages of construction. This early market exposure allows buyers the opportunity to customize the home. Plus, by placing more inventory on the market, as it is being built, expands the inventory of available homes, and that’s especially helpful for buyers and agents in a tight housing market.” ( See Chart 3 - New Home Sales Index – Days on Market – Monthly numbers 1 )

The HomesUSA.com® New Home Sales Index is the first index to track new home sales. Created by Caballero, who was named “ Most Innovative Real Estate Agent ” by real estate news firm Inman News, the index is an analysis by HomesUSA.com of sales of homes listed in the Dallas-Fort Worth, Houston, Austin and San Antonio local Multiple Listing Services (MLS). ( See Chart 4 - New Home Sales Index – Days on Market – Tracking )

1 Prior month DOM numbers are subject to adjustment Please note that the monthly data is based on information reported to the MLS that may be incomplete or subject to further revision by the MLS. While licensed real estate professionals are required to report closed sales to their local MLS in Texas within 72 hours of a closed sale, not all sales, unfortunately, are reported promptly, and some are published more than 30 days later. This late reporting causes the prior month's reported index number to change to include newly reported sales. Only the previous month index number is impacted and that number, once adjusted, is the final and correct index number. All averages for data provided are based on 12-month rolling averages.

About Ben Caballero and HomesUSA.com® Ben Caballero is the world’s most productive real estate agent, as recognized by Guinness World Records. Top-ranked in America by REAL Trends since 2013, as published in the Wall Street Journal, he is also the only agent to exceed $1 billion in residential sales transactions in a single year; a feat first achieved in 2015 and repeated each year since. An award-winning innovator , Caballero is the founder and CEO of HomesUSA.com ®, Inc., working with 64 home builders in Dallas-Fort Worth, Houston, Austin and San Antonio. Learn more at HomesUSA.com |Twitter: @bcaballero - @HomesUSA | Facebook: /HomesUSAdotcom.

Note for journalists: You may contact Ben Caballero directly on his cell at (214) 616-9222 or by email at ben@homesusa.com .

Images: Ben Caballero  http://waves.wavgroup.com/wp-content/uploads/...iteBkg.jpg

Chart 1 http://waves.wavgroup.com/wp-content/uploads/...PRICES.jpg

Chart 2 http://waves.wavgroup.com/wp-content/uploads/...-SALES.jpg

Chart 3 http://waves.wavgroup.com/wp-content/uploads/...-INDEX.jpg

Chart 4 http://waves.wavgroup.com/wp-content/uploads/...acking.jpg

Kevin Hawkins (206) 866-1220 kevin@wavgroup.com

Charts accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/Attachm...a360cd234d

http://www.globenewswire.com/NewsRoom/Attachm...1d76c39add

http://www.globenewswire.com/NewsRoom/Attachm...290428462f

http://www.globenewswire.com/NewsRoom/Attachm...99897cf124

A photo accompanying this announcement is available at

http://www.globenewswire.com/NewsRoom/Attachm...805a4916a3

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 81

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Pennsylvania Rebate Rules Matter Before Year-End Filing

Updated Category News Views 70

A missed rebate form can sting harder than most people expect, especially when a household has already spent the year watching property taxes, rent, groceries, and every other stubborn bill chew through fixed income. Pennsylvania’s Property Tax/Rent Rebate Program is not glamorous, and it is certainly not an investing story. It is, however, the kind of direct household...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 199

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 66

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 139

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 150

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 160

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading

Top 5 Most Recently Viewed Articles

Japan's Economic Outlook Dims as Export Weakness Persists

Updated Category News Views 189

Japan's Revised Economic Growth Forecast Recently, Japan's government announced a downward revision of its GDP growth forecast for the current fiscal year. This adjustment is significant as it reflects the ongoing struggles within the economy, particularly in light of weaker export performance that is hindering a fragile recovery. Details on the Growth Projection The...

Continue Reading
The Importance of Employee Recognition in the Workplace

Updated Category News Views 254

The Importance of Employee Recognition in the Workplace Gratitude is a key theme during Thanksgiving, but in the workplace, recognition for employee contributions plays an equally significant role throughout the year. As companies strive to enhance their workplace culture, the value of recognizing employees cannot be overstated. Understanding Employer Perspectives A...

Continue Reading
Class Action Alert for Shareholders of Orthofix Medical

Updated Category News Views 196

Class Action Lawsuit Overview In the current landscape of securities litigation, investors in Orthofix Medical, Inc. have a critical opportunity to engage with a class action lawsuit that addresses significant issues of corporate governance and transparency. This legal action has arisen following severe corporate management changes that have caused share price...

Continue Reading
Understanding Recent Trends in Lowe's Short Interest

Updated Category News Views 107

Understanding Lowe's Companies' Short Interest Lowe's Companies (NYSE: LOW) has seen its short percent of float decrease by 12.78% since the last report. Currently, there are approximately 6.55 million shares sold short, which constitutes 1.16% of all shares available for trading. Given the current trading volume, it would take traders about 2.91 days to cover their short...

Continue Reading
YD Bio Limited and EG Biomed Enhance Clinical Testing with CAP Accreditation

Updated Category News Views 151

Transformative Advancements in Clinical Testing by YD Bio Limited YD Bio Limited, a pioneering biotechnology company known for its advancements in DNA methylation-based cancer detection, recently celebrated a significant milestone through its collaboration with EG Biomed US Inc. This partnership has propelled forward the capabilities of clinical testing, particularly in...

Continue Reading